About Sepsis Diagnostics


Sepsis-Diagnostics.co.uk is a website that is dedicated to raising awareness amongst Clinicians, Laboratory Professionals and Pharmacists, about the value of rapid identification of pathogen species in cases of blood infection.

Alpha Laboratories


Alpha Laboratories Ltd

This website is published by Alpha Laboratories Limited, a company with extensive experience in the field of specialist diagnostic assays. You can read more about Alpha Laboratories here. The material on this site is intended only as informational or as an educational aid and it is not intended to be taken as medical advice. The ultimate responsibility for patient care resides with a healthcare professional.

You can also visit our main website here:

Visit the Alpha Laboratories Website


AdvanDx Inc.

Alpha Laboratories is the exclusive UK partner and distributor for AdvanDx, Inc. AdvanDx is widely recognised as the leading provider of rapid and accurate molecular diagnostic tests for identification of pathogens causing critical infections in hospitalised patients. You can also visit the AdvanDx website here:

Visit the AdvanDx Website




The information within the Sepsis Diagnostics website is aimed at professional health care personnel and is not designed as guidance for the general public. Similarly the products discussed are not suitable for personal purchase and self-testing.


If you have any personal concerns about Sepsis Diagnostics, Sepsis, Bacteraemia or Fungaemia, please speak to your GP.


If you would like further reading, please use the links at the bottom right hand corner of every page on this site.

About Sepsis Diagnostics

Sepsis is a potentially life-threatening condition caused by the presence of micro-organisms such as bacteria (bacteraemia) and fungi (fungaemia) in the bloodstream. Disease progression can be rapid so effective clinical intervention in these cases requires prompt diagnosis and identification of the responsible pathogen.

The QuickFISH system offers unprecedentedly fast (20 minute) species identification of pathogens directly from positive blood cultures, allowing the reporting of pathogen identification at the same time as the reporting of Gram stain results. Implementation of QuickFISH for sepsis diagnostics can deliver

  • Improved patient outcomes
  • Decreased financial outlay
  • Optimised antibiotic use
  • Decreased patient length of stay